WebJan 17, 2024 · Dr. Shubham Pant. Key Points: RAGNAR expansion cohort included adults with advanced or metastatic cholangiocarcinoma with predefined FGFR1-4alt whose disease had progressed after treatment with at least 1 line of systemic therapy.; Patients treated with erdafitinib had an ORR by independent review of 60%, with a median time to onset of … WebShubham Pant's 297 research works with 2,727 citations and 2,720 reads, ... Shubham Pant's research while affiliated with University of Texas MD Anderson Cancer Center and other places. Overview.
Did you know?
WebApr 10, 2024 · Shubham D Pant. Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center ... Rehabilitation, and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Karen M Basen-Engquist. Department of Health Disparities Research, The University of Texas MD … WebMonthly Plenary Series . Abstracts & Presentations
WebTotal downloads of all papers by Shubham Pant. If you need immediate assistance, call 877-SSRNHelp (877 777 6435) in the United States, or +1 212 448 2500 outside of the United States, 8:30AM to 6:00PM U.S. Eastern, Monday - Friday. WebJul 16, 2024 · 2024-0126 (Other Identifier: M D Anderson Cancer Center) NCI-2024-01441 (Registry Identifier: CTRP (Clinical Trial Reporting Program)) Drug and device information, study documents
WebProf. Shubham Pant is a Hematologist-Oncologist and an Associate Professor of Medicine at University of Texas MD Anderson Cancer Center in Houston. He previously served as the Director of Clinical Trials for the Section of Hematology-Oncology and Associate Director of the Tobacco Settlement Endowment Trust (TSET) Phase 1 program, for the Stephenson … WebJul 22, 2024 · Shubham Pant & Timothy A. Yap. Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. …
WebRoberto Carmagnani Pestana, Justin T Moyers, Jason Roszik, Shiraj Sen, David S Hong, Aung Naing, Cynthia E Herzog, Siqing Fu, Sarina A Piha-Paul, Jordi Rodon, Timothy A Yap, Daniel D Karp, Apostolia M Tsimberidou, Shubham Pant, Maria A Zarzour, Ravin Ratan, Vinod Ravi, Robert S Benjamin, Alexander J Lazar, Wei-Lien Wang, Najat Daw, Jonathan B Gill, Douglas …
WebPostdoctoral Fellow. MD Anderson Cancer Center. Jul 2011 - Dec 20154 years 6 months. Houston, Texas Area. open plant officeWebMar 27, 2024 · Shubham Pant MD [email protected] ... Correspondence. Shubham Pant, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. Email: [email protected] Search for more papers by this author. Erika Hamilton MD, Erika Hamilton MD. open playground iaWebDr. Shubham Pant, MD is a Medical Oncology Specialist in Houston, TX and has over 22 years of experience in the medical field. ... Ut MD Anderson Cancer Center 1515 … ipad pro 9.7 bypass unlocktoolWebHe joined the faculty of MD Anderson Cancer Center in 1997, where his research has focused on the treatment of pancreatic cancer. He has been a collaborator with surgical oncologists, radiation oncologists, and laboratory researchers in trying to understand the causes of pancreatic cancer and to design better treatment strategies for resectable, … open playerWebOncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats. open platform for education opeWebJul 14, 2024 · PURPOSE The response to cancer therapies is typically assessed with radiologic imaging 6-10 weeks after treatment initiation. Circulating tumor DNA (ctDNA), however, has a short half-life, and dynamic changes in ctDNA quantity may allow for earlier assessment of the therapeutic response. METHODS Patients with advanced solid tumors … open play cheltenham activity campWebDr. Shubham Pant, MD is an oncologist in Oklahoma City, Oklahoma. He is affiliated with University of Texas M.D. Anderson Cancer Center. openplatform technology company limited